Old Web
English
Sign In
Acemap
>
authorDetail
>
Yuko Sato
Yuko Sato
University of Texas MD Anderson Cancer Center
Molecular biology
ABL
Leukemia
Growth inhibition
K562 cells
2
Papers
103
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation.
2009
Blood
Yukimasa Shiotsu
Hitoshi Kiyoi
Yuichi Ishikawa
Ryohei Tanizaki
Makiko Shimizu
Hiroshi Umehara
Kenichi Ishii
Yumiko Mori
Kazutaka Ozeki
Yosuke Minami
Akihiro Abe
Hiroshi Maeda
Tadakazu Akiyama
Yutaka Kanda
Yuko Sato
Shiro Akinaga
Tomoki Naoe
Show All
Source
Cite
Save
Citations (102)
KW-2449, a Novel Multi-Kinase Inhibitor, Suppresses the Growth of Imatinib-Resistant Ph+ Leukemia Including BCR-ABL/T315I Both in Vitro and in Vivo.
2008
Blood
Yukimasa Shiotsu
Hitoshi Kiyoi
Ryohei Tanizaki
Yosuke Minami
Akihiro Abe
Yuichi Ishikawa
Kenichi Ishii
Makiko Shimizu
Yutaka Kanda
Yuko Sato
Shiro Akinaga
Jorge E. Cortes
Tomoki Naoe
Show All
Source
Cite
Save
Citations (1)
1